Moderna | Passifs Courants



Current Liabilities Changement Date
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
Adcock Ingram Holdings ZAR 2.81B 279.84M 2024-12
Agios Pharmaceuticals USD 70.41M 18.04M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 20.48B 2.53B 2025-06
Arrowhead Research USD 194.53M 26.01M 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Celltrion KRW 3.4T 216.25B 2025-03
Cspc Pharmaceutical CNY 9.63B 801.28M 2024-12
Dianthus Therapeutics USD 20.09M 1.64M 2025-06
Divis Laboratories Ltd 14.52B 1.61B 2025-03
Gilead Sciences USD 11.19B 1.15B 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
Incyte USD 1.28B 608.18M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Kangmei Pharma CNY 5.75B 64.58M 2025-06
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 186.51M 29.86M 2025-06
Malin Corporation EUR 1000K 500K 2024-12
Moderna USD 1.57B 32M 2025-06
Organigram Holdings CAD 107.28M 38.32M 2025-06
Pharma Mar EUR 87.78M 8.29M 2025-06
Qiagen NV USD 1.13B 611.37M 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Sartorius EUR 1.55B 72.7M 2025-06
Sino Biopharmaceutical CNY 19.56B 2.39B 2024-12
Tilray USD 278.52M 15.02M 2024-11
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
United Therapeutics USD 527.1M 194.4M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06
Zz Pientze Pharmaceu 3.2B 878.89M 2025-06


Moderna Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.